Pholcodine 5mg/5ml linctus sugar free

Country: United Kingdom

Language: English

Source: MHRA (Medicines & Healthcare Products Regulatory Agency)

Buy It Now

Active ingredient:

Pholcodine

Available from:

Pinewood Healthcare

ATC code:

R05DA08

INN (International Name):

Pholcodine

Dosage:

1mg/1ml

Pharmaceutical form:

Oral solution

Administration route:

Oral

Class:

Schedule 5 (CD Inv)

Prescription type:

Valid as a prescribable product

Product summary:

BNF: 03090100; GTIN: 5099186000244 5099186001272

Patient Information leaflet

                                148
148
210
210
PATIENT INFORMATION LEAFLET
PHOLCODINE LINCTUS BP
Pholcodine BP 5 mg/5 ml
Read all of this leaflet carefully because it contains important
information for you.
This medicine is available from your pharmacy without prescription,
however, you still need to take Pholcodine Linctus
carefully to get the best results from it.
- Keep this leaflet. You may need to read it again.
- Ask your pharmacist if you need more information or advice.
- You must contact a doctor if your symptoms worsen or do not improve
after a few days.
- If any of the side effects gets serious, or if you notice any side
effects not listed in this leaflet, please tell your doctor or
pharmacist.
In this leaflet:
1. What Pholcodine Linctus is and what it is used for
2. Before you take Pholcodine Linctus
3. How to take Pholcodine Linctus
4. Possible side effects
5. How to store Pholcodine Linctus
6. Further information
1. WHAT PHOLCODINE LINCTUS IS AND WHAT IT IS USED FOR
Pholcodine Linctus 5 mg/5 ml is a medicine which helps you to stop
coughing, especially if you have a dry non-productive
cough. It is related to morphine and codeine, and it acts to stop your
automatic cough response.
2. BEFORE YOU TAKE PHOLCODINE LINCTUS
It’s normal for children to get 8 or more colds in a year. Because
colds are caused by viruses, not bacteria, antibiotics don’t
help. Here are simple steps to help your child who has a cough or
cold.
1.
If they are hot/feverish: Increase the amount of fluid your child
normally drinks. Lower their temperature with a
paracetamol or ibuprofen medicine which has doses for children.
2.
For coughs: Coughing serves a purpose, it helps clear phlegm and
mucous. Give the child plenty of warm clear
fluids to drink.
3.
To help with breathing: Plain saline nose drops/sprays can help with
blocked noses.
Do not take Pholcodine Linctus if you have:
• an allergy (hypersensitivity) to pholcodine or any of the other
ingredients of Pholcodine Linctus
_(see Section 6 and_
_ end of Section 2)._
• liver disease.
• breathing probl
                                
                                Read the complete document
                                
                            

Summary of Product characteristics

                                OBJECT 1
PHOLCODINE LINCTUS BP
Summary of Product Characteristics Updated 27-Jul-2015 | Pinewood
Healthcare
1. Name of the medicinal product
Pholcodine Linctus BP
2. Qualitative and quantitative composition
Each 5 ml contains Pholcodine BP 5 mg
For a full list of excipients, see section 6.1
3. Pharmaceutical form
Clear orange viscous syrup
4. Clinical particulars
4.1 Therapeutic indications
Adults: Cough suppressant for relief of acute non-productive cough
associated with upper respiratory
tract infection
Children of 6-12 years of age: Cough suppressant for relief of acute
non-productive cough associated with
upper respiratory tract infection.
4.2 Posology and method of administration
Adults: 10 ml up to six times daily.
Dosage should be reduced in elderly or debilitated patients.
Children 6-12 years: 5 ml up to four times daily
Pholcodine is contraindicated in children under the age of 6 years
(see section 4.3)
Children of 6-12 years of age: not to be used for more than 5 days
without the advice of a doctor. Parents
or carers should seek medical attention if the child's condition
deteriorates during treatment
Do not exceed the stated dose
Keep out of the reach and sight of children
4.3 Contraindications
Pholcodine should not be given to subjects in or at risk of developing
respiratory failure as the sedative
properties of pholcodine may exacerbate the condition.
Patients with chronic bronchitis, COPD, bronchiolitis or
bronchiectasis due to sputum retention
Patients taking monoamine oxidase inhibitors (MAOIs) or within 14 days
of stopping such treatment (see
also section 4.5).
Patients with hypersensitivity or idiosyncratic response to pholcodine
or to any of the excipients.
Patients with liver disease since pholcodine is metabolised in the
liver and the drug may accumulate.
Not to be used in children under the age of 6 years.
4.4 Special warnings and precautions for use
1. Should be used with caution by patients with liver or renal
impairment
2. Ask a doctor before use if you suffer from a chronic or persistent

                                
                                Read the complete document
                                
                            

Search alerts related to this product